Content overview: “India Cuts Cancer Drug Prices After Supreme Court Rules Mark-Ups Are 'Extortion'”. The government's decision aims to curb profiteering by hospitals and pharmacists and make cancer care more accessible. This intervention is expected to significantly lower out-of-pocket expenses for patients, who bear a heavy burden in a country where healthcare costs are largely private. The ruling is a wake-up call for the pharmaceutical industry and could lead to broader price controls on essential medicines. Nova Global News curates publicly available headlines and summaries with source attribution.
Third-party article rights, trademarks, images, and publisher names belong to their respective owners; read the original article at the source for full context. Part of the Nova Ecosystem — the platform where AI apps, news, and tools are built and deployed. The full version stays on the original page, which this listing opens directly.